Vor BiopharmaVOR

13F holders, Q4 2025 (December 31)
55holders +19
28new positions
10sold out
3famous investors
$13.00avg. 13F price*

At the end of Q4 2025, 55 institutions reported holding Vor Biopharma Inc. (VOR) in their 13F filings, up 19 from Q3 2025. 28 opened new positions and 10 sold out. The largest holders were Ra Capital Management, L.P. ($70.7M), FCPM III Services B.V. ($47.3M) and Frazier Life Sciences Management, L.P. ($33.3M). 3 famous investors held it, including Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Vor Biopharma Inc.
CUSIP
929033207
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150 Q1 2025: 1Q1 2025Q2 2025: 1Q2 2025Q3 2025: 36Q3 2025Q4 2025: 55Q4 2025Q1 2026: 80Q1 2026Q2 2026: 102Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions28$105.8M
Exits10$12.1M

All 13F filers, Q3 2025 → Q4 2025: 21,095,498 shares bought and 258,682 shares sold, net +20,836,816 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 55 holders

Ra Capital Management, L.P. 0.72% Add +172.7% 5,404,998 $70.7M
FCPM III Services B.V. 6.20% Add +852.8% 3,617,354 $47.3M
Frazier Life Sciences Management, L.P. 0.90% New 2,543,939 $33.3M
FMR LLC 0.00% Add +968.1% 2,526,170 $33.0M
Venrock Adviser, LLC 1.26% Add +288.8% 1,943,766 $25.4M
Paradigm Biocapital Advisors LP 0.61% New 1,750,000 $22.9M
Great Point Partners LLC 5.81% New 1,370,107 $17.9M
NEXTBio Capital Management LP 7.67% — 999,967 $13.1M
Vanguard Group Inc. 0.00% Add +632.3% 770,250 $10.1M
Caligan Partners LP 0.91% New 925,067 $10.0M
BlackRock, Inc. 0.00% Add +1248.5% 465,636 $6.1M
Citadel Advisors 0.00% Add +7530.9% 433,894 $5.7M
Sphera Funds Management LTD. 1.12% New 410,417 $5.4M
Laurion Capital Management LP 0.29% New 317,243 $4.1M
UBS Group AG 0.00% Add +284.8% 292,118 $3.8M
Findell Capital Management LLC 1.00% New 231,000 $3.0M
Millennium Management 0.00% Add +806.7% 224,534 $2.9M
Geode Capital Management, LLC 0.00% Add +578.3% 185,808 $2.4M
Tudor Investment Corporation 0.01% New 167,673 $2.2M
Ameriprise Financial Inc. 0.00% New 163,061 $2.1M
Goldman Sachs Group Inc. 0.00% Add +822.6% 145,640 $1.9M
Logos Global Management LP 0.09% New 100,000 $1.3M
Jane Street Group, LLC 0.00% Add +448.0% 91,810 $1.2M
State Street Corp. 0.00% Add +905.7% 91,053 $1.2M
Johnson & Johnson 0.13% New 53,732 $703K
Northern Trust Corp. 0.00% New 38,946 $509K
Morgan Stanley 0.00% Add +538.8% 28,463 $372K
Engineers Gate Manager LP 0.00% New 28,204 $369K
Quadrature Capital Ltd 0.00% New 26,791 $350K
Sarissa Capital Management LP 0.15% No change 25,399 $332K
Bollard Group LLC 0.01% Add +763.8% 23,987 $314K
OMERS ADMINISTRATION Corp 0.00% New 20,700 $271K
Squarepoint Ops LLC 0.00% Add +290.3% 18,459 $241K
XTX Topco Ltd 0.01% New 17,542 $229K
Independent Financial Group, LLC 0.01% New 17,000 $222K
Susquehanna International Group, LLP 0.00% New 14,819 $194K
Persistent Asset Partners Ltd 0.07% New 10,798 $141K
Shay Capital LLC 0.02% New 10,745 $141K
Susquehanna Portfolio Strategies, LLC 0.00% New 10,207 $134K
Chung Wu Investment Group, LLC 0.09% New 8,300 $109K
Citigroup Inc. 0.00% New 6,340 $83K
Hudson Bay Capital Management LP 0.00% New 5,110 $67K
China Universal Asset Management Co., Ltd. 0.00% New 2,746 $36K
JPMorgan Chase & Co. 0.00% Add +2864.1% 2,312 $30K
Tower Research Capital LLC (TRC) 0.00% Add +43125.0% 1,729 $23K
Barclays PLC 0.00% New 1,399 $18K
Mirae Asset Global Investments Co., Ltd. 0.00% New 819 $11K
Bank of America Corp. 0.00% Reduce -91.7% 396 $5K
GF Fund Management Co. LTD. 0.00% New 330 $4K
BNP Paribas Financial Markets 0.00% Reduce -95.2% 291 $4K
MAI Capital Management 0.00% No change 40 $524
Allworth Financial LP 0.00% No change 3 $40
SBI Securities Co., Ltd. 0.00% No change 3 $39
Wells Fargo & Company 0.00% No change 1 $13
Royal Bank of Canada 0.00% Add +250.0% 7 $0

"% of holder's portfolio" is VOR's weight in each manager's 13F, not the share of Vor Biopharma Inc. the manager owns.